Loading clinical trials...

COMPLETEDPhase 2NCT03180684

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

The purpose of this study is to test the safety and efficacy of an investigational immunotherapy VGX-3100, in combination with a study device, to treat women with vulvar high-grade squamous intraepith...

Lead sponsor: Inovio Pharmaceuticals•15 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

NCT03792516 · Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, and more

COMPLETEDNA

Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia

NCT02875561 · Vulvar Intraepithelial Neoplasia (VIN)

COMPLETEDPhase 3

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

NCT00394758 · Vulvar Dysplasia, Vaginal Dysplasia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 25, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment33

Start dateAug 2017

Last updatedAug 25, 2023

Condition

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar Dysplasia Vulvar Intraepithelial Neoplasia (VIN)VIN2 VIN3+2 more

Locations shown

Christiana Care Health Systems

Newark, Delaware

Augusta University

Augusta, Georgia

Rush University Medical Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 25, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions